Arcturus Therapeutics
Price & Volume
Stats
See moreOpen | $6.80 |
Previous Close | $6.71 |
Day Range | $6.54-$6.80 |
52W Range | $5.85-$24.17 |
Market Cap | $194.1M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $54.7M |
Revenue Growth (YoY) | -93% |
Gross Profit (12 Mos) | -$44.1M |
Diluted EPS | -$2.83 |
News
See moreYahoo Finance • 3 months ago
Cathie Wood's ARK boosts Palantir, Tesla, Roninhood bets; cuts semiconductor exposure
Yahoo Finance • 4 months ago
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Yahoo Finance • 4 months ago
These Are the Only 3 Stocks That Cathie Wood Bought Last Week
Yahoo Finance • 4 months ago
Arcturus outlines 12-week Phase II CF trial launch and expects regulatory clarity for ARCT-810 in 2026
About
CEO | Mr. Joseph E. Payne M.Sc. |
Address | 10285 Science Center Drive, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 106 |